Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL 1711: A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
Grant
Overview
Affiliation
Overview
Date/time Interval
December 13, 2017 - December 12, 2022
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
54500.00
Direct Costs
40073.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator
Elizabeth Alva
Investigator
Emily Johnston
Investigator
Gregory Friedman M.D.
Principal Investigator
Jamie Aye
Investigator
Kimberly Whelan M.D.
Investigator
Laura Metrock
Investigator
Matthew Kutny M.D.
Investigator
Wayne Liang
Investigator